WHO issues global guideline on the use of GLP-1 medicines in treating obesity at AshTip Solution.

AshTip NewsLetter |1 December 2025 | Geneva –To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health Organization (WHO) has released its first guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a

PAHO Org

WHO issues global guideline on the use of GLP-1 medicines in treating obesity

WHO issues global guideline on the use of GLP-1 medicines in treating obesity

1 December 2025 | Geneva –To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health Organization (WHO) has released its first guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a chronic, relapsing disease.Obesity affects people in every country…